Blog
RSS FeedPosted by Michael Wonder on 06 Feb 2017
NICE to bring HTA processes to mobile health apps
2 February 2017 - But its new evidence briefings will stop short of issuing guidance on their use. ...
Posted by Michael Wonder on 06 Feb 2017
Medicines evaluation not keeping pace with scientific progress, says ABPI
3 February 2017 - Following the news that a new breast cancer medicine - palbociclib - from Pfizer has been ...
Posted by Michael Wonder on 06 Feb 2017
Australian families reconsider having health insurance with premiums tipped to rise
6 February 2017 - Many health insurance customers will reconsider whether it’s worthwhile having cover if prices continue to climb ...
Posted by Michael Wonder on 06 Feb 2017
Parliament House rally to call for potentially life-saving drugs for cystic fibrosis patients to be listed on the PBS
6 February 2017 - Toddler Dash Dewey is believed to be one of 30 children in Australia living with a ...
Posted by Michael Wonder on 06 Feb 2017
Funding cuts threat for radiation patients
6 February 2017 - Radiologists have warned that a $23.7 million cut to federal support for cancer-fighting equipment will undermine ...
Posted by Michael Wonder on 05 Feb 2017
Mental health cover a battleground for private health insurers
5 February 2017 - Excluding care like mental health from cheaper health insurance policies is proving to be a big ...
Posted by Michael Wonder on 05 Feb 2017
Riverina mother to tackle government over PBS' refusal to list cystic fibrosis drug
5 February 2017 - A government decision to keep a revolutionary drug out of the hands of desperate parents has ...
Posted by Michael Wonder on 04 Feb 2017
Drug game-changer for thousands suffering from cystic fibrosis headed for the PBS
5 February 2017 - Australia's youngest cystic fibrosis sufferers will this week get a massive reprieve when the government lists ...
Posted by Michael Wonder on 04 Feb 2017
Most important breast cancer drug in two decades will not get NHS funding
3 February 2017 - A new drug described as one of the "most important" advances in treating breast cancer ...
Posted by Michael Wonder on 04 Feb 2017
Healthcare ‘bravery’ needed, says HBF boss Bransby
4 February 2017 - The Turnbull government needs to be “brave” and tackle “hideous” healthcare costs, health insurance boss Rob ...
Posted by Michael Wonder on 03 Feb 2017
Breast cancer drug costs too high in relation to benefits for routine NHS funding
3 February 2017 - NICE does not recommend breast cancer drug palbociclib (Ibrance, Pfizer) because its cost is too high in ...
Posted by Michael Wonder on 03 Feb 2017
Influenza vaccine in pharmacies
3 February 2017 - PHARMAC proposes changes to the Pharmaceutical Schedule to fund the provision of influenza vaccine (flu vaccine) ...
Posted by Michael Wonder on 03 Feb 2017
Agenda for 8 February 2017 TC meeting
3 February 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 02 Feb 2017
Potential drug price hike could be a hard pill to swallow
3 February 2017 - New Zealand may have to swallow higher drug prices if it wants a trade deal with the ...
Posted by Michael Wonder on 02 Feb 2017
Mind the gap - an analysis of cancer medicines in New Zealand and Australia
2 February 2017 - When it comes making a difference in people’s lives, it’s not about how many medicines you ...